epilepsy — cannabigerol | Proposal Forge

auto_awesome

Want to know who else bid on this?

Proposal Forge correlates this contract with the original RFP, the losing bidders, and the next recompete window.

Open the Bid Intelligence reportarrow_forward

Recipient

epilepsy

Department

Unknown

Program

cannabigerol

Province

among other effects. The pharmacology of THC is relatively well-established: THC is a CB1R and CB2R partial agonist and a GPR18 and GPR55 full agonist. The pharmacology of CBD is far-less clear. CBD has been described as a CB1R negative allosteric modulator

Type

GPR55

Agreement Number

affect cellular biology. This work will contribute to our understanding of how Cannabis affects the body in order to inform policy

Purpose

and cannabivarin (CBDV). Although some studies have already been conducted to demonstrate the potential medical value of a subset of these compounds - such as THCV and CBDV - in treating conditions such as epilepsy

epilepsy × Unknown

1 grants totalling $0

cannabigerol

1 grants totalling $0

Department

Unknown →

Program

cannabigerol →

Recipient Profile

epilepsy →